Regencell Bioscience Holdings (RGC) Current Leases (2022 - 2025)

Regencell Bioscience Holdings' Current Leases history runs 4 years deep, the most recent figure standing at $258124.0 for Q4 2025.

• Quarterly Current Leases changed N/A year-over-year to $258124.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $258124.0 (changed N/A YoY) and the FY2025 annual result came in at $312780.0, up 422.98% from the prior year.
• Current Leases was $258124.0 for Q4 2025 at Regencell Bioscience Holdings, down from $312780.0 in the prior quarter.
• Across five years, Current Leases topped out at $438263.0 in Q2 2023 and bottomed at $59807.0 in Q2 2024.
• A 4-year average of $295992.2 and a median of $312780.0 in 2025 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases sank 86.35% — and 2025, when it surged 422.98%.
• Regencell Bioscience Holdings' Current Leases stood at $410987.0 in 2022, then rose by 6.64% to $438263.0 in 2023, then sank by 86.35% to $59807.0 in 2024, then surged by 331.59% to $258124.0 in 2025.
• Business Quant data shows RGC's Current Leases at $258124.0 in Q4 2025, $312780.0 in Q2 2025, and $59807.0 in Q2 2024.